Physician profile

Hector M Lopez

Family Medicine · Greenfield, WI

NPI 1952389876

$5,054.82

in general payments reported to CMS, 2019-2025

37 companies · $977 in 2025

The $977 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,004.91

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $1,100.20 2019-2025 Farxiga, Airsupra, Breztri
Novo Nordisk INC $571.99 2021-2025 Ozempic, Rybelsus, Wegovy
Abbott Laboratories $455.35 2021-2025 Freestyle Libre 3
Pfizer INC. $355.47 2019-2025
Abbvie INC. $311.85 2021-2025
Lilly USA, LLC $310.81 2021-2025 Mounjaro, Zepbound, Trulicity
Merck Sharp & Dohme LLC $285.29 2019-2025 Gardasil 9, Capvaxive, Vaxelis
Bayer Healthcare Pharmaceuticals INC. $156.52 2022-2025
Exact Sciences Corporation $152.24 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Novartis Pharmaceuticals Corporation $140.79 2023-2024
Nestle Healthcare Nutrition INC. $137.60 2021-2023
Dexcom, INC. $131.36 2023-2025 Dexcom G6 Transmitter
Boehringer Ingelheim Pharmaceuticals, INC. $98.90 2019-2025 Jardiance
Convatec INC. $89.22 2022
Glaxosmithkline, LLC. $87.24 2020-2024 Shingrix, Arexvy
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $86.73 2019-2025 Spravato
Astellas Pharma US INC $84.41 2023-2024 Veozah
Xeris Pharmaceuticals, INC. $53.72 2024-2025 Gvoke Hypopen
Takeda Pharmaceuticals U.S.A., INC. $38.72 2021
Sanofi-Aventis U.S. LLC $37.09 2022
Aimmune Therapeutics, INC. $36.84 2024-2025 Zenpep
Allergan, INC. $33.37 2019
Kowa Pharmaceuticals America, INC. $31.32 2024-2025 Zoryve
Teva Pharmaceuticals USA, INC. $30.03 2021-2022
Amphastar Pharmaceuticals, INC. $28.98 2025 Baqsimi
Ultragenyx Pharmaceutical INC. $24.14 2022
Biohaven Pharmaceutical Holding Company LTD. $21.45 2022
Daiichi Sankyo INC. $19.19 2021
Bausch Health US, LLC $18.39 2022
Biohaven Pharmaceuticals, INC. $18.35 2021
Phathom Pharmaceuticals, INC. $18.14 2024 Voquezna
Vertex Pharmaceuticals Incorporated $16.96 2024
Sanofi Pasteur INC. $16.27 2021
Paratek Pharmaceuticals, INC. $15.74 2024 Nuzyra
Rhythm Pharmaceuticals, INC. $14.63 2024 Imcivree
Hologic Sales and Service, LLC $14.20 2020
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $11.32 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Hector M Lopez

$5,054.82

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $977 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/224907/hector-m-lopez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.